Company Filing History:
1 out of 164 
1 out of 35 
Years Active: 2020
Title: Christian Steuer: Innovator in Peptidomimetics
Introduction
Christian Steuer is a notable inventor based in Zurich, Switzerland. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel compounds that can modulate the GLP-1 receptor. His work is particularly relevant for the treatment of type 2 diabetes.
Latest Patents
Christian Steuer holds a patent for "Backbone-cyclized peptidomimetics with GLP-1R modulating activity." This patent describes a novel class of backbone-cyclized peptidomimetics characterized by the general formula cyclo[-P-P-P-P-P-P-P-P-T-T-]. The individual elements T or P represent α-amino acid residues that are connected in various orientations. These compounds have the potential to modulate the GLP-1 receptor, making them valuable as medicaments for treating, preventing, or delaying diseases where GLP-1 receptor modulation is beneficial.
Career Highlights
Christian Steuer has worked with prestigious institutions such as the University of Zurich and Polyphor AG. His experience in these organizations has allowed him to advance his research and contribute to the scientific community significantly.
Collaborations
Some of his notable coworkers include Daniel Obrecht and Christian Bisang. Their collaborative efforts have likely enhanced the research and development of innovative solutions in the field of medicinal chemistry.
Conclusion
Christian Steuer's work in developing backbone-cyclized peptidomimetics represents a significant advancement in the treatment of type 2 diabetes. His contributions to the field highlight the importance of innovation in addressing complex medical challenges.